A novel and efficient tandem CD19- and CD22-directed CAR for B cell ALL
2021 · Molecular Therapy · 40 citations
https://doi.org/10.1016/j.ymthe.2021.08.033
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
40
Papers
1.3K
Citations
18
h-index
23
i10-index
Francisco Gutiérrez‐Agüera is an academic researcher from Josep Carreras Leukaemia Research Institute. The author has contributed to research in topics: CAR-T cell therapy research & Acute Lymphoblastic Leukemia research & Acute Myeloid Leukemia Research. The author has an h-index of 18, co-authored 34 publications.
ORCID: 0000-0002-8620-2839https://doi.org/10.1016/j.ymthe.2021.08.033
https://doi.org/10.1016/j.exphem.2022.07.191
Click to start Chat